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Abstract
A follow-up study of colour vision in two patients with gyrate atrophy was performed. Gyrate atrophy was diagnosed in the
first patient at the age of 17 years. Her colour vision was first tested at the age of 25 years; at the follow-up examination 7 years
later, she correctly interpreted the Standard Pseudoisochromatic Plates part 2, however, with one mistake due to lens opacity. In
the Farnsworth–Munsell 100 hue test and in the Color Vision Meter 712 (CVM) anomaloscope, the results were within normal
ranges. In the second patient, gyrate atrophy was diagnosed at the age of 4 years. At the ages of 4 and 5 years, he correctly
interpreted the Ishihara, AO H-R-R, and Lanthony Tritan Album plates as well as the City University test. At the ages of 6, 7,
and 8 years, he correctly interpreted the plate tests, the Farnsworth Panel D 15, and Lanthony’s Desaturated Panel. The CVM
anomaloscope results were normal. © 1998 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Gyrate atrophy is a hereditary chorioretinal dystro-
phy characterized by round whitish atrophic spots in
the periphery of the eye fundus. This disease has been
found to begin in childhood or at school age. However,
the disease has even been reported in a 1-year-old [1].
Onset at adult age has also been observed [2]. High
myopia, poor visual acuity, decreased dark adaptation,
and defects in visual fields are found in an eye examina-
tion. These findings progress gradually with age, and at
late middle age these patients can be severely visually
handicapped because of visual loss and concentric con-
striction of the visual fields. Gyrate atrophy is inherited
as an autosomal recessive trait, and it belongs to
Finnish inherited diseases, the frequency being highest
in Finland, 1:50000 [3,4]. A metabolic error—a high
ornithine level—has been found in the blood of these
patients due to a defect in the ornithine-aminotrans-
ferase enzyme [1]. The therapy consists of a low
arginine diet with pyridoxine supplementation. The
gene of this disease has been mapped to chromosome
10, 10 q 26 [5].
Normal colour vision [2,6,7] as well as acquired red
defects [8–10], blue defects [2,6], achromatopsia [11]
and irregular colour vision defects without diagnosis
[6,12] have been observed in patients with gyrate
atrophy.
The purpose of the present study is to report follow-
up observations of colour vision in two patients with
gyrate atrophy.
2. Results
2.1. Case reports
2.1.1. Case 1
Gyrate atrophy was diagnosed in this 31-year-old
woman at the age of 17 years. Colour vision was regu-
larly studied since she was 25 years of age. Her blood
ornithine level was eight times higher than normal, and
subsequent genetic studies also confirmed the disease.
She had been under treatment only for 4 years, from
the age of 25 years until her first pregnancy at the age
of 29. As she wants to have more children, she has
further refused therapy. During the follow-up, her vi-
sual acuity decreased from 0.5 to 0.3 (6:12–6:18) in the
right and from 0.4 to 0.1 (6:15–6:60) in the left eye.* Corresponding author. Fax: 358 17 172486.
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Fig. 1. Fundus of the right eye of the 31 year old patient with gyrate atrophy.
Her myopic refraction progressed from 12.5 diopters
(D) cyl 2.0 D15° to 13.0 D cyl 2.75 D10°
in the right and from 9.75 D cyl 2.5 D160° to
12.0 D cyl 2.75 D150° in the left eye. In the
latest examination, the visual fields (Peristat, Roden-
stock, Munich, Germany) were tubular, 15° in the right
and 10° in the left eye. In the dark adaptation examina-
tion, the cone threshold was normal and the rod
threshold was elevated 0.8 log units in both eyes (Gold-
mann-Weekers, Haag-Streit, Bern, Switzerland). Very
slight onset of a posterior pole cataract was detected in
both eyes from the age of 28 years. In the left eye, the
cataract had progressed to a dense opacity in the latest
examination. In both eyes, the eye fundus showed
typical multiple round white atrophic spots in the pe-
riphery (Fig. 1). She interpreted the Standard Pseu-
doisochromatic Plates part 2 [13] correctly; only on the
latest visit did the left eye with the cataract miss one of
the blue numbers. In the Farnsworth–Munsell 100 hue
test, FM 100 [14], she had normal age-matching error
scores [15,16] without axis formation [17] during the
follow-up (Table 1); on the latest visit, because of the
cataract, the error scores of the left eye had increased
being at the upper limit of the normal score. The Color
Vision Meter 712 automatic anomaloscope, CVM (In-
terzeag, Schlieren, Switzerland) results were normal and
nearly the same on every visit (Table 1).
2.1.2. Case 2
Gyrate atgrophy was diagnosed in this 8-year-old
boy at the age of 4 years. Initially, his visual acuity was
0.2 (6:30) in both eyes with a refraction of 3.0 D cyl
3.5 D5° in the right and 3.5 D cyl 3.0 D0°
in the left eye. The visual acuity could be better exam-
ined as the patient grew older; at the age of 8 years, it
was 0.5 (6:12) in both eyes. The myopic refraction had
become higher, being 5.0 D cyl 3.5 D15° in the
right and 6.0 D cyl 3.0 D0° in the left eye. In
the eye fundus, the typical multiple round white at-
rophic spots were seen. Examination of the visual fields
was unreliable, but could be interpreted as tubular,
15° in the right and 20° in the left eye (Friedman
Central Field Analyzer, Clement Clarke, London, UK).
It has not yet been possible to perform the dark adap-
tation examination. His blood ornithine level was
20 times higher than normal, and subsequent genetic
studies also confirmed the disease. He has been under
therapy since the diagnosis was made; however, his
blood ornithine level is still high. At the age of 4 or
5, very few colour vision tests can be reliably used.
We examined the patient with Ishihara’s Design
Charts for Colour-Blindness of Unlettered Persons
[18], Lanthony Tritan Album [19], AO H-R-R plates
[20], and the City University test [21]. The patient
could interpret these tests very reliably, showing nor-
mal results in both eyes. At the ages of 6–8 years, he
passed the plate tests as well as the Farnsworth Panel
D 15 [22]. He could also do the difficult Lanthony
Desaturated Panel [23] without any major errors.
Moreover, the CVM anomaloscope could be used at
the ages of 7 and 8, and the results were normal (Table
2).
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Table 1
The results in the FM 100 test and the CVM anomaloscope examinations of the 31 year old patient with gyrate atrophy (Case 1)
25 26Test 28Age (years) 30 31
Dx Sin Dx Sin Dx SinEye Dx Sin Dx Sin
12.1FM 100 in square roots 10.6 10.2 10.6 10.3 10.6 9.5 12.7
CVM
5 0 1 0 1Red-green 0MR 2 1 1 1
1.0 0.9 0.9 1.0 0.9AQ 0.9 0.8 1.1 0.9 1.2
3 2Blue MR 1 1 1 0.9 1 1
0.9 1.0 1.1 0.9 1.3 2AQ 1.2 0.9
FM 100, Farnsworth–Munsell 100 hue test; CVM. Color Vision Meter 712; MR, matching range; AQ, anomalous quotient; Dx, right eye; Sin,
left eye.
3. Discussion
The colour vision of our gyrate atrophy patients aged
31 and 8 years was observed for 7 and 5 years, respec-
tively, and found to be normal. However, there were
changes within normal ranges in the adult patient, Case
1. The first FM 100 test of the right eye at the age of
26 years probably produced a poor score because of the
newness of the test for the patient. The score of the left
eye was already better then and within the normal
range; it has been observed in earlier studies too that the
performance of the FM 100 hue test can improve with
experience [16]. The following years showed quite simi-
lar scores within the normal limits in both eyes in the
FM 100 test except on the last visit, when the progress-
ing cataract most probably decreased the score of the
left eye. Her CVM anomaloscope results were normal in
both eyes. The results were almost the same in the
red-green equation in the right eye during the follow-up,
but had a tendency to shift to green in the left eye,
probably also because of the developing cataract. The
blue equation was about the same during the follow-up
in both eyes, although one would have expected to see
a shift to blue in the cataractous left eye.
In the younger patient, Case 2, the CVM anomalo-
scope testing was possible at the ages of 7 and 8 years,
and the results were within the normal ranges. The
red-green equation was quite similar in both eyes, but
the blue equation showed a slight shift within the
normal range to blue in the right eye. The matching
ranges of the blue equation in both eyes were at the
upper limit of normal, as frequently observed in young
children, but in some adults too.
It is surprising that colour vision can show normal
function even if fundus changes are extensive and the
visual fields are almost tubular. Probably the cone area
responsible for colour vision is quite narrow at the fovea
and so the influence of the peripheral atrophic changes
reaches this area much later. In a study of a family
with dominant retinitis pigmentosa in three generations,
the oldest member of the family had tubular fields of
about 10° in both eyes but still had normal colour vision
[24].
Reports on the therapy of gyrate atrophy are contro-
versial: the therapy with reduced blood ornithine level
has not always prevented the deterioration of eye func-
tions [25,26]. On the other hand, the results of Kaiser-
Kupfer et al. [1] have shown that long-term reduction of
blood ornithine level slows the progression of this
disease. Our younger patient, Case 2, also had therapy,
but his blood ornithine level had remained high. The
adult patient, Case 1, had had the therapy only for
4 years and had been without it for 3 years at the time
of this study. It is thus difficult to claim that the
preserved colour vision in our patients is due to the
therapy.
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